Loading insider details...
Beta
Latest Form 4 (Aug 15, 2026): Grant/Award of 38,627 NEOG shares, $450.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 15, 2026 | NEOGEN CORP (NEOG) | Grant/Award | 38,627 | $450.0K |
| Jun 26, 2026 | Context Therapeutics Inc. (CNTX) | Grant/Award | 45,000 | n/a |
| May 4, 2026 | NEOGEN CORP (NEOG) | Grant/Award | 39,349 | $375.0K |
| Jun 12, 2025 | Context Therapeutics Inc. (CNTX) | Grant/Award | 123,500 | n/a |
| Jun 14, 2024 | Context Therapeutics Inc. (CNTX) | Grant/Award | 25,000 | n/a |
| May 31, 2023 | Context Therapeutics Inc. (CNTX) | Grant/Award | 25,000 | n/a |
| Feb 28, 2023 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 135,000 | n/a |
| Jun 3, 2022 | Context Therapeutics Inc. (CNTX) | Grant/Award | 25,000 | n/a |
| Mar 2, 2022 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 75,000 | n/a |
| Oct 13, 2021 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 130,000 | n/a |